New anabolic therapies for osteoporosis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Emergency Medicine,Internal Medicine
Link
http://link.springer.com/article/10.1007/s11739-017-1719-4/fulltext.html
Reference47 articles.
1. Papapoulos SE (2015) Anabolic bone therapies in 2014: new bone-forming treatments for osteoporosis. Nat Rev Endocrinol 11:69–70. doi: 10.1038/nrendo.2014.214
2. Freemantle N, Cooper C, Roux C et al (2010) Baseline observations from the POSSIBLE EU® study: characteristics of postmenopausal women receiving bone loss medications. Arch Osteoporos 5:61–72. doi: 10.1007/s11657-010-0035-7
3. Holloway KL, Henry MJ, Brennan-Olsen SL et al (2016) Non-hip and non-vertebral fractures: the neglected fracture sites. Osteoporos Int 27:905–913. doi: 10.1007/s00198-015-3322-8
4. Hernlund E, Svedbom A, Ivergård M et al (2013) Osteoporosis in the European Union: medical management, epidemiology and economic burden: a report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos 8(1–2):136. doi: 10.1007/s11657-013-0136-1
5. Romagnoli E, Carnevale V, Nofroni I et al (2004) Quality of life in ambulatory postmenopausal women: the impact of reduced bone mineral density and subclinical fractures. Osteoporos Int 15:975–980. doi: 10.1007/s00198-004-1633-2
Cited by 29 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. METTL14-mediated HOXA5 m6A modification alleviates osteoporosis via promoting WNK1 transcription to suppress NLRP3-dependent macrophage pyroptosis;Journal of Orthopaedic Translation;2024-09
2. Towards an enhanced understanding of osteoanabolic effects of PTH-induced microRNAs on osteoblasts using a bioinformatic approach;Frontiers in Endocrinology;2024-07-17
3. Physicians’ awareness of medication-related osteonecrosis of the jaw in patients with osteoporosis;PLOS ONE;2024-01-26
4. Insights into the Mechanism of Osteoporosis and the Available Treatment Options;Current Pharmaceutical Biotechnology;2023-11-02
5. Terapia anabolica dell’osteoporosi nel 2023;L'Endocrinologo;2023-09-14
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3